INTRODUCTION
F e t a l m a c r o s o m i a , polyhydramnios and overgrowth with prenatal cardiac abnormalities u s u a l l y s u g g e s t m a t e r n a l hyperglycemia. However in case of fetal weight exceeding 5000g at 32 weeks of gestation a rare genetic syndrome should be taken into consideration and multispecialist team at the referral center might be helpful in making diagnosis and prognosis for the family.
CASE REPORT
It was the first pregnancy of a 39 years old woman, who had a normal first trimester scan and nuchal translucency (NT) at 13 detected and, after excluding maternal diabetes and thyroid disease, the pregnant woman was referred to our tertiary center for further evaluation. At the 28 th week of gestation fetal biometry was consistent with the 35 th week of gestation and suggested fetal weight based on basic parameters such as biparietal diameter, head circumference, abdominal circumference and femur length (BPD, HC, Ac and FL) was 3666 +/-535g and the subcutaneous tissue at the femur level was 6 mm thick ( Fig. 1, 2, 3 ). In 3D ultrasound fetal face seemed relatively mature without evidence of dysmorphic features, however probably with a deep and broad nasal bridge (Fig. 4) .
Fetal echocardiography showed a normal fetal heart anatomy ( Fig. 5, 6 ), however the cardiac axis was 90 degrees, (possibly due to hepatomegaly) and there was mild cardiomegaly with heart area/chest area ratio (HA/CA) was 0,4, but the heart diameter at the level of mitral and tricuspid valves was 48 mm. There was significant dilatation of superior vena cava up to 7,8 mm and pulmonary outflow tract at the level of the mediastinum was 12 mm.
The shortening fractions of LV and RV based on M-mode were 32% and 28%, respectively. The Tei index for the LV 0,45 and for the RV was 0,5.
Due to polyhydramnios (AFI =30 cm) the patient was referred for amnioreduction as an inpatient.
The next ultrasonography and echocardiography exam in our center was performed 4 weeks later as an out-patient again. At that time there was maternal right leg edema due to thrombosis of her popliteal vein. The fetal biometry suggested an estimated fetal weight of approximately 6000 g, polyhydramnios (AFI= 40cm), increasing ascites, increased fetal kidney size (57 mm long ), (Fig. 7, 8 ).
There was also polydactyly of the right hand (Fig. 12) .
Fetal echocardiography showed cardiomegaly, with a heart diameter at the level of mitral and tricuspid valve of 55 mm, disproportion at the atrial level (RA > LA), disproportion at the ventricular level (RV > LV) and again there was an abnormal mediastinal view with dilatation of the SVC up to 9, 6 mm . Prenatal findings suggested significant macrosomia, f e t a l / m y o c a r d i a l hypertrophy consistent with neonatal congestive heart failure and a severe neonatal condition after delivery with a poor prognosis for survival.
Due to increasing maternal discomfort with dyspnea and leg oedema 4 days later , at 33 weeks of gestation, an elective cesarean section was performed and a baby boy was delivered with a birth weight of 5050 g and Apgar score of 4. There was an unusual appearance of the fetal face, and a superficialfacial haemangioma. He had also several deep skin tumors and polydactyly ( Fig. 12 ) a protuberant a b d o m e n , a n d abnormally thick skin. There was maternal and medical consensus for conservative management and not to treat the congestive heart failure. On the 3 rd day of postnatal life there was a neonatal demise. The autopsy revealed at 6 cm capillary angio tumor below the liver, 3 cm capillary vascular tumor of the right thigh, partial anomalous venous connection (right pulmonary veins to the superior vena cava and left pulmonary veins to the left atrium).
Taking into consideration the possibility of Costello syndrome, a genetic evaluation was performed in our institute. DNA was extracted from whole peripheral blood using the MagCore Genomic DNA Whole Blood Kit ( R B C B i o s c i e n c e ) , with informed consent of the child's mother. Amplification of the coding exons and flanking intronic sequences of the HRAS gene was performed using the primer pairs designed based on the reference genomic sequence NM_005343 GRCh38/hg38 (Table 1) .
PCR contained 50 ng of genomic DNA as template, 10 pmol of each primer (2,5 μl), 200 μM of dNTPs (0,5 μl), and 0,2 μl FastStart Taq DNA polymerase (Roche) in 10x PCR buffer contains 20 mM MgCl 2 (2,5 μl). PCR was carried out with initial enzyme activation at 95°C for 4 minutes, followed by 30 cycles of denaturation at 95°C for 30 seconds, annealing at 55°C for exon 2, 56°C for exons 3 and 4, 53°C for exon 5 for 1 minute and extension at 72°C for 45 seconds, with a final extension at 72°C for 7 minutes. The quality and quantity of PCR products were checked by 2% agarose gel electrophoresis. 
PCR products were used for sequencing reaction by BigDye Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems). Sequencing products were analysed by capillary electrophoresis on an ABI 3500 Genetic Analyzer (Applied Biosystems). The alignment to reference sequence was performed using Mutation Surveyor 5.0.1 software. No pathogenic mutations were detected in the analyzed gene.
DISCUSSION:
In the case of prenatal ultrasound findings such as increased nuchal translucency Based on the clinical findings , other diagnoses were also taken into consideration, such as Leopard Syndrome, Beckwith -Wiedemann Syndrome, Perlman S y n d r o m e a n d Simpson-Golabi-Behmel Syndrome ( Table 2 ). The difficulties are related to overlaping symptoms and sonographic findings. The clinical features described for these syndromes in Omim and in Pub-Med are usually related to postnatal findings in infancy or later. Therefore the presented case recognized from prenatal life provides important data, although the final genetic diagnosis was not clear..
Based on the clinical findings, the most likely diagnosis in our case may be Costello Syndrome (Table 3 ) 7 , and in 2016 by Uemura 8 ( Table 2 ).
The main reason f o r r e f e r r a l i n t h e presented case was fetal cardiomegaly and myocardial hypertrophy at the 24 th week of gestation (after a normal 1 st trimester scan in a high risk pregnancy due to advanced maternal age) detected by an obstetrician trained in fetal echocardiography. During a subsequent targeted examination in our tertiary unit, in addition to cardiomegaly and myocardial hypertrophy, the dilatation of superior Fetal macrosomia, polyhydramnios and cardiac anomalies may be helpful to predict poor outcome in neonate -case report of a possible fetal RASopathy with sonographic and neonatal findings and genetic evaluation vena cava was present suggesting partial anomalous pulmonary venous connection 13 later confirmed by autopsy.
T h e i m p o r t a n c e o f f e t a l echocardiography in fetuses with extracardiac anomalies has been demonstrated many times 14, 15 and associated with different malformations [16] [17] [18] [19] .
Further important sonographic features were acceleration in fetal growth up 5000 g at 32 week of gestation, the rapid progression of ascites and of polyhydramios, which all caused maternal dyspnea and leg edema, leading to elective cesarean section. This observation exemplifies our previous study and recommendations concerning the important role of the fetal echocardiographic study in the third trimester 20, 21 . Also multiple huge tumors (capillary haemangiomas) both in the skin and abdomen are important and important to report as they are very rarely seen in newborns.
Skin and tumor manifestations in neonates are rare and also have been reported in Costello Syndrome as rhabdomyosarcoma 22, 23 Smith and coworkers 24 compiled from parent surveys that the most common prenatal findings in the literature in this cohort were polyhydramnios and fetal overgrowth with relative macrocephaly. Lurie (1994) 25 They also found a significant increase of mean paternal age (38.0 years); in our case, the paternal age was 40 years.
Other diagnoses included also Noonan Syndrome (often with an increased NT in the 1 st trimester), Sotos syndrome, mucopolysaccharidoses and brain abnormalities (Gripp) 26 .
Generation Prenatal Diagnosis (NGPD), a new targeted approach that allows to concurrently investigate all the genes involved in the RASopathies were not available for us. Their molecular characterization is complex, time consuming and expensive. The lack of confirmation of a mutation in HRAS gene does not exclude disorders in the whole RAS gene family (mostly protooncogens). The phenotype of the fetus was most suggestive of Costello Syndrome, but, the most common syndrome in this family of disorders is Noonan Syndrome, usually with an increased NT in the first trimester., In RAS/MAPK signaling pathways an important role is also played by gene NF. This gene acts like a suppressor gene and it can also influence many other genes in the chain KRAS/MAPK, so it can trigger a wide phenotypic variety.
Despite that in our referral center the final diagnosis was not established , we considered it important to report this case in order to add information to the medical literature from the natural history study as suggested by Lin
27
. It is also worth noting that normal sonographic findings in the first half of pregnancy does not rule out lethal complex malformations which may develop in the second half of pregnancy. On the other hand survival in Costello Syndrome or RASopathies is possible and both parents and pateints have created a support group such as in France (http://afscostello-cfc.asso.fr/category/association/ CONCLUSIONS:
1. Significant acceleration of fetal growth in second half of pregnancy and polyhydramnios were the first symptoms of abnormal fetal growth and development despite normal first half of pregnancy (both clinically and sonographically).
2. Fetal echocardiography revealed cardiomegaly, myocardial hypertrophy, dilatation of the superior vena cava suggesting partial anomalous venous return and was helpful to predict the poor outcome. 
